Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease

Hepatology International

Volumn 2, Issue 2, 2008, Pages 202-208

  Bhardwaj, Payal ^a   Madan, Kaushal ^a   Thareja, Sandeep ^a   Joshi, Yogendra Kumar ^a   Saraya, Anoop ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alcoholic liver disease; Antioxidant status; Nonalcoholic fatty liver disease; Oxidative stress

Indexed keywords

ALCOHOL; ASCORBIC ACID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 58349104620     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-008-9060-7     Document Type: Article

References (46)

1. 1. M Sugimoto T Sadamoto H Nonaka 2003 Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis Nihon Arukoru Yakubutsu Igakkai Zasshi 38 1 34 45 12687723 Sugimoto M, Sadamoto T, Nonaka H. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2003;38(1):34–45.
2. 2. M Nakano T Fukusato 2005 Histological study on comparison between NASH and ALD Hepatol Res 33 2 110 5 16219486 10.1016/j.hepres.2005.09.016 Nakano M, Fukusato T. Histological study on comparison between NASH and ALD. Hepatol Res. 2005;33(2):110–5.
3. 3. M Nakano 2005 Histological study on the resemblance and difference between non-alcoholic steatohepatitis (NASH) and alcoholic liver diseases (ALD) Alcohol Clin Exp Res 29 Suppl 12 230S 5S 16385228 Nakano M. Histological study on the resemblance and difference between non-alcoholic steatohepatitis (NASH) and alcoholic liver diseases (ALD). Alcohol Clin Exp Res. 2005;29(Suppl 12):230S–5S.
4. 4. B Halliwell 1987 Oxidants and human disease: some new concepts FASEB J 1 5 358 64 2824268 1:CAS:528:DyaL1cXltlGnuw%3D%3D Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1987;1(5):358–64.
5. 5. GE Arteel 2003 Oxidants and antioxidants in alcohol-induced liver disease Gastroenterology 124 778 90 12612915 10.1053/gast.2003.50087 1:CAS:528:DC%2BD3sXisVKnt74%3D Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology. 2003;124:778–90.
6. 6. PD Masalkar SA Abhang 2005 Oxidative stress and antioxidant status in patients with alcoholic liver disease Clin Chim Acta 355 1–2 61 5 15820479 10.1016/j.cccn.2004.12.012 1:CAS:528:DC%2BD2MXivFyqtbk%3D Masalkar PD, Abhang SA. Oxidative stress and antioxidant status in patients with alcoholic liver disease. Clin Chim Acta. 2005;355(1–2):61–5.
7. 7. HE Hirnwich LH Nahum N Pakieten JF Fazekas DU Bots 1982 Effects of alcohol on metabolism Am J Physiol 101 57 68 Hirnwich HE, Nahum LH, Pakieten N, Fazekas JF, Bots DU. Effects of alcohol on metabolism. Am J Physiol. 1982;101:57–68.
8. 8. M Morimotto AI Hagbjork AA Nariji 1992 Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis Free Rad Biol Med 10 459 64 Morimotto M, Hagbjork AI, Nariji AA. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Free Rad Biol Med. 1992;10:459–64.
9. 9. S Seki T Kitada H Sakaguchi 2005 Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases Hepatol Res 33 2 132 4 16198621 10.1016/j.hepres.2005.09.020 1:CAS:528:DC%2BD2MXht1GnurjN Seki S, Kitada T, Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res. 2005;33(2):132–4.
10. 10. M Koruk S Taysi MC Savas O Yilmaz F Akcay M. Karakok 2004 Oxidative stress and enzymatic status in patients with nonalcoholic steatohepatitis Ann Clin Lab Sci 34 57 62 15038668 1:CAS:528:DC%2BD2cXislyjurs%3D Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci. 2004;34:57–62.
11. 11. G Perlemuter A Davit-Spraul C Cosson M Conti A Bigorgne V Paradis 2005 Increase in liver antioxidant enzyme activity in non-alcoholic fatty liver disease Liver Int 25 5 946 53 16162151 10.1111/j.1478-3231.2005.01126.x 1:CAS:528:DC%2BD2MXhtFGiu7zE Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, Paradis V, et al. Increase in liver antioxidant enzyme activity in non-alcoholic fatty liver disease. Liver Int. 2005;25(5):946–53.
12. 12. AJ Sanyal C Campbell-Sargent F Mirshahi 2001 Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 1183 92 11266382 10.1053/gast.2001.23256 1:CAS:528:DC%2BD3MXjtVeqsb8%3D Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183–92.
13. 13. K Madan P Bhardwaj S Thareja S Dattagupta A Saraya 2006 Oxidant stress and antioxidant status among patients with non-alcoholic fatty liver disease (NAFLD) J Clin Gastroenterol 40 10 930 5 17063114 10.1097/01.mcg.0000212608.59090.08 1:CAS:528:DC%2BD28XhtFWns7rF Madan K, Bhardwaj P, Thareja S, Dattagupta S, Saraya A. Oxidant stress and antioxidant status among patients with non-alcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006;40(10):930–5.
14. 14. SA Harrison S Torgerson P Hayashi 2003 Vitamin E and vitamin C treatment improves fibrosis in patients with non alcoholic steatohepaitis Am J Gastroenterol 98 2485 90 14638353 10.1111/j.1572-0241.2003.08699.x 1:CAS:528:DC%2BD3sXpt1Sgu7k%3D Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with non alcoholic steatohepaitis. Am J Gastroenterol. 2003;98:2485–90.
15. 15. SQ Yang H Zhu Y Li 2000 Mitochondrial adaptations to obesity related oxidant stress Arch Biochem Biophys 378 259 68 10860543 10.1006/abbi.2000.1829 1:CAS:528:DC%2BD3cXktVGqsbY%3D Yang SQ, Zhu H, Li Y, et al. Mitochondrial adaptations to obesity related oxidant stress. Arch Biochem Biophys. 2000;378:259–68.
16. 16. P Letteron B Fromenty B Terris 1996 Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice J Hepatol 24 200 8 8907574 10.1016/S0168-8278(96)80030-4 1:STN:280:DyaK2s%2FmtlOjtQ%3D%3D Letteron P, Fromenty B, Terris B, et al. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol. 1996;24:200–8.
17. 17. JJF Belch AB Bridges N Scott M Chopra 1991 Oxygen free radicals and congestive heart failure Brit Heart J 65 215 8 10.1136/hrt.65.5.245 Belch JJF, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Brit Heart J. 1991;65:215–8.
18. 18. S Marklund G. Marklund 1974 Involvement of superoxide anion radical in the autooxidation of pyragallol and a convenient assay for SOD Eur J Biochem 47 469 74 4215654 10.1111/j.1432-1033.1974.tb03714.x 1:CAS:528:DyaE2MXhtlGm Marklund S, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyragallol and a convenient assay for SOD. Eur J Biochem. 1974;47:469–74.
19. 19. M Okamura 1980 An improved method for determination of l-ascorbic acid and l-dehydroascorbic acid in blood plasma Clin Chem Acta 103 259 68 10.1016/0009-8981(80)90144-8 1:CAS:528:DyaL3cXks1Git7s%3D Okamura M. An improved method for determination of l-ascorbic acid and l-dehydroascorbic acid in blood plasma. Clin Chem Acta. 1980;103:259–68.
20. 20. IFF Benzie JJ Strain 1996 The ferric reducing ability of plasma (FRAP) as a measure of “Antioxidant Power”: the FRAP assay Anal Biochem 239 70 6 8660627 10.1006/abio.1996.0292 1:CAS:528:DyaK28XksFCmt7Y%3D Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “Antioxidant Power”: the FRAP assay. Anal Biochem. 1996;239:70–6.
21. 21. CS Lieber 1984 Metabolism and metabolic effects of alcohol Med Clin North Am 68 1 3 31 6361415 1:CAS:528:DyaL2cXhtFGrt70%3D Lieber CS. Metabolism and metabolic effects of alcohol. Med Clin North Am. 1984;68(1):3–31.
22. 22. R Nordmann C Ribiere H Rouach 1992 Implication of free radical mechanisms in ethanol induced cellular injury Free Rad Biol Med 12 219 40 1563648 10.1016/0891-5849(92)90030-K 1:CAS:528:DyaK38XitV2iurs%3D Nordmann R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol induced cellular injury. Free Rad Biol Med. 1992;12:219–40.
23. 23. Zima T Kalousova M 2005 Oxidative stress and signal transduction pathways in alcoholic liver disease Alcohol Clin Exp Res 29 Suppl 11 110S 15S 16344594 10.1097/01.alc.0000189288.30358.4b Zima T, Kalousova M. Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol Clin Exp Res. 2005;29(Suppl 11):110S–15S.
24. 24. S Chitturi J George 2003 Interaction of iron, insulin resistance and non-alcoholic steatohepatitis Curr Gastroenterol Rep 5 1 18 25 12530944 10.1007/s11894-003-0005-y Chitturi S, George J. Interaction of iron, insulin resistance and non-alcoholic steatohepatitis. Curr Gastroenterol Rep. 2003;5(1):18–25.
25. 25. G Robertson I Leclercq GC Farrell 2001 Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress Am J Physiol Gastrointest Liver Physiol 281 5 G1135 9 11668021 1:CAS:528:DC%2BD3MXos1ags7w%3D Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol. 2001;281(5):G1135–9.
26. 26. H Kojima S Sakurai M Uemura T Takekawa H Morimoto 2005 Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver diseases Alcohol Clin Exp Res 29 Suppl 12 259S 63S 16385233 Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, et al. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver diseases. Alcohol Clin Exp Res. 2005;29(Suppl 12):259S–63S.
27. 27. T Suematsu T Matsumura N Sato T Miyamoto T Ooka T Kamada 1981 Lipid peroxidation in alcoholic liver disease in humans Alcohol Clin Exp Res ;5 3 427 30 7025695 10.1111/j.1530-0277.1981.tb04926.x Suematsu T, Matsumura T, Sato N, Miyamoto T, Ooka T, Kamada T, et al. Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res. 1981;5(3):427–30.
28. 28. HK Vincent AG Taylor 2006 Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans Int J Obes (Lond) 30 3 400 18 10.1038/sj.ijo.0803177 1:CAS:528:DC%2BD28Xhsl2htb0%3D Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond). 2006;30(3):400–18.
29. 29. C Couillard G Ruel WR Archer S Pomerleau J Bergeron P Couture 2005 Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity J Clin Endocrinol Metab 90 12 6454 9 16189262 10.1210/jc.2004-2438 1:CAS:528:DC%2BD2MXhtlaltL%2FL Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab. 2005;90(12):6454–9.
30. 30. D Pessayre B Fromenty 2005 NASH: a mitochondrial disease J Hepatol 42 6 928 40 15885365 10.1016/j.jhep.2005.03.004 1:CAS:528:DC%2BD2MXktVGmtL8%3D Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol. 2005;42(6):928–40.
31. 31. P Kovacs M Stumvoll 2005 Fatty acids and insulin resistance in muscle and liver Best Pract Res Clin Endocrinol Metab 19 4 625 35 16311221 10.1016/j.beem.2005.07.003 1:CAS:528:DC%2BD2MXht1GhsLbN Kovacs P, Stumvoll M. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab. 2005;19(4):625–35.
32. 32. P Letteron A Sutton A Mansouri B Fromenty D Pessayre 2003 Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice Hepatology 38 1 133 40 12829995 10.1053/jhep.2003.50309 1:CAS:528:DC%2BD3sXlvFaju70%3D Letteron P, Sutton A, Mansouri A, Fromenty B, Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 2003;38(1):133–40.
33. 33. K Begriche A Igoudjil D Pessayre B Fromenty 2006 Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it Mitochondrion 6 1 1 28 16406828 10.1016/j.mito.2005.10.004 1:CAS:528:DC%2BD28XhsFyru7k%3D Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006;6(1):1–28.
34. 34. P Moriel FL Plavnik MT Zanella MC Bertolami DS Abdalla 2000 Lipid peroxidation and antioxidants in hyperlipidemia and hypertension Biol Res 33 2 105 12 15693277 1:CAS:528:DC%2BD3MXhtVamsbs%3D 10.4067/S0716-97602000000200010 Moriel P, Plavnik FL, Zanella MT, Bertolami MC, Abdalla DS. Lipid peroxidation and antioxidants in hyperlipidemia and hypertension. Biol Res. 2000;33(2):105–12.
35. 35. A Szuster-Ciesielska J Daniluk M Kandefer-Szerszen 2001 Alcohol-related cirrhosis with pancreatitis. The role of oxidative stress in the progression of the disease Arch Immunol Ther Exp (Warsz) 49 2 139 46 1:CAS:528:DC%2BD3MXlvVamt7k%3D Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M. Alcohol-related cirrhosis with pancreatitis. The role of oxidative stress in the progression of the disease. Arch Immunol Ther Exp (Warsz). 2001;49(2):139–46.
36. 36. S Kubota N Sato T Matsumura T Kamada 1985 Chemiluminescence and superoxide dismutase in the plasma in patients with alcoholic and non-alcoholic liver injuries Alchol 2 3 469 72 10.1016/0741-8329(85)90117-X 1:STN:280:DyaL2M3nvFymtA%3D%3D Kubota S, Sato N, Matsumura T, Kamada T. Chemiluminescence and superoxide dismutase in the plasma in patients with alcoholic and non-alcoholic liver injuries. Alchol. 1985;2(3):469–72.
37. 37. OR Koch ME Leo De S Borrello G Palombini T. Galeotti 1994 Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver Biochem Biophys Res Commun 201 3 1356 65 8024580 10.1006/bbrc.1994.1853 1:CAS:528:DyaK2cXksFahsr0%3D Koch OR, De Leo ME, Borrello S, Palombini G, Galeotti T. Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver. Biochem Biophys Res Commun. 1994;201(3):1356–65.
38. 38. LA Videla R Rodrigo M Orellana V Fernandez G Tapia L Quinones 2004 Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients Clin Sci 106 261 268 14556645 10.1042/CS20030285 1:CAS:528:DC%2BD2cXisVyrtL8%3D Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quinones L, et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci. 2004;106:261–268.
39. 39. M Koruk S Taysi MC Savas O Yilmaz F Akcay M Karakok 2004 Oxidative stress and enzymatic status in patients with nonalcoholic steatohepatitis Ann Clin Lab Sci 34 57 62 15038668 1:CAS:528:DC%2BD2cXislyjurs%3D Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci. 2004;34:57–62.
40. 40. PD MacLean EC Drake L Ross C Barclay 2007 Bilirubin as an antioxidant in micelles and lipid bilayers: its contribution to the total antioxidant capacity of human blood plasma Free Radic Biol Med 43 4 600 9 17640570 10.1016/j.freeradbiomed.2007.05.020 1:CAS:528:DC%2BD2sXotVWrs74%3D MacLean PD, Drake EC, Ross L, Barclay C. Bilirubin as an antioxidant in micelles and lipid bilayers: its contribution to the total antioxidant capacity of human blood plasma. Free Radic Biol Med. 2007;43(4):600–9.
41. 41. K Hagymási A Blázovics G Lengyel I Kocsis J. Fehér 2001 Oxidative damage in alcoholic liver disease Eur J Gastroenterol Hepatol 13 1 49 53 11204809 10.1097/00042737-200101000-00009 Hagymási K, Blázovics A, Lengyel G, Kocsis I, Fehér J. Oxidative damage in alcoholic liver disease. Eur J Gastroenterol Hepatol. 2001;13(1):49–53.
42. 42. PM Abuja 1999 Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein FEBS Lett 446 305 8 10100863 10.1016/S0014-5793(99)00231-8 1:CAS:528:DyaK1MXhvVCmtbc%3D Abuja PM. Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett. 1999;446:305–8.
43. 43. WH Pan KM Flegal HY Chang WT Yeh CJ Yeh WC Lee 2004 Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians Am J Clin Nutr 79 31 39 14684394 1:CAS:528:DC%2BD2cXhsFyltw%3D%3D Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr. 2004;79:31–39.
44. 44. T Ogura K Matsuura Y Matsumoto Y Mimura M Kishida F Otsuka 2004 Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002 Metabolism 53 448 53 15045690 10.1016/j.metabol.2003.11.017 1:CAS:528:DC%2BD2cXisVSmu7s%3D Ogura T, Matsuura K, Matsumoto Y, Mimura Y, Kishida M, Otsuka F, et al. Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002. Metabolism. 2004;53:448–53.
45. 45. G Notas N Miliaraki M Kampa F Dimoulios E Matrella A Hatzidakis 2005 Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay World J Gastroenterol 11 27 4194 8 16015688 Notas G, Miliaraki N, Kampa M, Dimoulios F, Matrella E, Hatzidakis A, et al. Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay. World J Gastroenterol. 2005;11(27):4194–8.
46. 46. G Cao SL Booth JA Sadowski RL Prior 1998 Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables Am J Clin Nutr 68 5 1081 7 9808226 1:CAS:528:DyaK1cXntFOntbo%3D Cao G, Booth SL, Sadowski JA, Prior RL. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr. 1998;68(5):1081–7.